Answers are grounded in this paper and cite their sources.
This study compared the efficacy and safety of 75% hypertonic glucose and polidocanol-containing formulations for treating lower-limb microvessels. A descriptive and comparative literature review with a qualitative approach was conducted, focusing on three clinical trials: Bertanha et al. (2017), Bertanha et al. (2021), and Fonseca et al. (2023). Vessel reduction, pain, adverse events, number of sessions, and patient satisfaction were examined when reported. In the Bertanha trials, formulations containing 0.2% polidocanol in 70% glucose showed greater vessel reduction than 75% glucose alone. In the Fonseca trial, in which both groups also received Nd:YAG laser treatment, conventional photographic assessments showed no significant between-group differences. Available evidence did not support definitive conclusions regarding the number of sessions or patient satisfaction. Findings should be interpreted in light of vessel type, formulation, treatment protocol, and follow-up period. Individualized treatment decisions and clinical safety remain essential.
No takes yet. Share an insight, caveat, or question.
Lopes et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: